Hostname: page-component-74656f9884-8rzl6 Total loading time: 0 Render date: 2026-11-06T03:09:41.365Z Has data issue: false hasContentIssue false

Biological embedding of neighborhood disadvantage and collective efficacy: Influences on chronic illness via accelerated cardiometabolic age

Published online by Cambridge University Press:  14 August 2018

Man-Kit Lei*
Affiliation:
University of Georgia
Steven R. H. Beach
Affiliation:
University of Georgia
Ronald L. Simons
Affiliation:
University of Georgia
*
Address correspondence and reprint requests to: Man-Kit Lei, Department of Sociology, University of Georgia, 217B Baldwin Hall, Athens, GA 30602-4527; E-mail: karlo@uga.edu.
Rights & Permissions [Opens in a new window]

Abstract

The present study extends prior research on the link between neighborhood disadvantage and chronic illness by testing an integrated model in which neighborhood characteristics exert effects on health conditions through accelerated cardiometabolic aging. Hypotheses were tested using a sample of 408 African Americans from the Family and Community Health Study. Using four waves of data spanning young adulthood (ages 18–29), we first found durable effects of neighborhood disadvantage on accelerated cardiometabolic aging and chronic illness. Then, we used marginal structural modeling to adjust for potential neighborhood selection effects. As expected, accelerated cardiometabolic aging was the biopsychosocial mechanism that mediated much of the association between neighborhood disadvantage and chronic illness. This finding provides additional support for the view that neighborhood disadvantage can influence morbidity and mortality by creating social contexts that becomes biologically embedded. Perceived neighborhood collective efficacy served to buffer the relationship between neighborhood disadvantage and biological aging, identifying neighborhood-level resilience factor. Overall, our results indicate that neighborhood context serves as a fundamental cause of weathering and accelerated biological aging. Residing in a disadvantaged neighborhood increases biological wear and tear that ultimately leads to onset of chronic illness, but access to perceived collective efficacy buffers the impact of these neighborhood effects. From an intervention standpoint, identifying such an integrated model may help inform future health-promoting interventions.

Information

Type
Special Issue Articles
Copyright
Copyright © Cambridge University Press 2018 
Figure 0

Figure 1. Theoretical model linking neighborhood disadvantage to cardiometabolic aging and ultimately chronic illness response. The model indicates that the theoretical link is mediated and moderated by perceived neighborhood collective efficacy.

Figure 1

Table 1. Correlations between chronic illness, cardiometabolic aging, and biomarkers

Figure 2

Table 2. Multilevel regression models examining effects of neighborhood disadvantage on accelerated cardiometabolic aging

Figure 3

Table 3. Multilevel Poisson regression models examining effects of neighborhood disadvantage on chronic illness

Figure 4

Figure 2. Path model of the relationship between early and later neighborhood disadvantage on accelerated cardiometabolic aging. *p ≤ .05, **p ≤ .01 (two-tailed tests).

Figure 5

Figure 3. Path model of the relationship between early and later neighborhood disadvantage on chronic illness. *p ≤ .05, **p ≤ .01 (two-tailed tests).

Figure 6

Table 4. Descriptive statistics for time-varying and time-invariant covariates in the inverse probability treatment weighting

Figure 7

Figure 4. Scatter plot representing the association between neighborhood disadvantage and accelerated cardiometabolic aging using Framingham algorithm. The solid line displays the predicted regression line, and the dashed lines are the 95% confidence interval for the fitted line. Predicted scores represent residual biological age after controlling for chronological age (N = 408).

Figure 8

Table 5. Pooled regression models using four waves (ages 18 to 29) of data examining effects of neighborhood disadvantage on accelerated cardiometabolic aging and chronic illness

Figure 9

Figure 5. The effect of neighborhood disadvantage on accelerated cardiometabolic aging by level of perceived collective efficacy. Vertical bars indicate the 95% confidence interval (N = 408).

Figure 10

Table 6. Pooled regression models using four waves (ages 18 to 29) of data examining the relationships among neighborhood disadvantage, perceived collective efficacy, and accelerated cardiometabolic aging